-
Mashup Score: 4Patient Profile: A 49-Year-Old Woman with HR+/HER2- mBC and Liver and Lung Metastases - 1 day(s) ago
Anne P. O’Dea, MD, presents the case of a 49-year-old woman with HR+/HER2- metastatic breast cancer and offers initial impressions on the patient’s risk and prognosis.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Debu Tripathy, MD, highlights the potential role and significance of vepdegestrant in pretreated ER-positive/HER2-negative breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 17MBC Impact Series: Metastatic Inflammatory Breast Cancer - 2 day(s) ago
Watch this previously recorded webinar to hear about the latest treatments and research on inflammatory breast cancer from Dr. Wendy Woodward of MD Anderson.
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4
Komal L. Jhaveri, MD, FACP, presents key data on the addition of inavolisib to palbociclib and fulvestrant vs palbociclib and fulvestrant alone in select patients with PIK3CA-mutated, hormone receptor–positive, HER2-negative, locally advanced, or metastatic breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 10
A Study of Dato-DXd With or Without Durvalumab Versus Investigator’s Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0
Debu Tripathy, MD, highlights the potential role and significance of vepdegestrant in pretreated ER-positive/HER2-negative breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
DCISionRT is a risk-assessment test for patients designed to predict RT benefit and develop their recurrence risk after surgery alone or with radiation.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population‐based study - 5 day(s) ago
For patients with breast cancer with initial bone metastasis, clinicians can use this nomogram based on population studies to assess whether patients can benefit from surgery of the primary tumor les…
Categories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5
During a Case-Based Roundtable® event, Hope S. Rugo, MD, FASCO, moderated a discussion on treatment options for a patient whose breast cancer recurred several years after adjuvant therapy.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Supporting Patients With Breast Cancer: How Nurses Can Maximize Opportunities for Connection | Cancer Nursing Today - 6 day(s) ago
Panelists discuss how nurses can connect with patients who are receiving breast cancer treatment and how reducing treatment time benefits patients and clinics.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
WATCH: Anne P. O'Dea, MD, presents the case of a 49-year-old woman with HR+/HER2- metastatic breast cancer and offers initial impressions on the patient’s risk and prognosis. #BCSM | @KUHospital https://t.co/yD0gQctOCI